View Article

Abstract

Costus igneus Nak and Costus pictus D. Don, commonly referred to as the Spiral flag, belong to the family Costaceae and are relatively recent introductions to India from South and Central America. These plants are perennial in nature, growing upright with a spreading habit, and typically reach a height of about two feet. They are characterized by spirally arranged leaves and visually appealing flowers. In southern regions of India, the plant is widely cultivated as an ornamental species, and its leaves are traditionally consumed as a dietary supplement for managing diabetes. In recent years, several scientific studies have investigated its antidiabetic activity. In addition to this, the plant has demonstrated multiple pharmacological properties such as lipid-lowering, diuretic, antioxidant, antimicrobial, and anticancer effects. Phytochemical investigations have identified the presence of carbohydrates, proteins, triterpenoids, alkaloids, tannins, saponins, flavonoids, steroids, and trace elements. The present work aims to review and summarize the available literature on the phytochemical composition and pharmacological activities reported for this plant to date.

Keywords

Costus igneus Nak, Costus pictus D. Don, anti-diabetic activity, diabetes mellitus, insulin plant.

Introduction

Costus igneus Nak, commonly referred to as fiery costus, spiral flag or the insulin plant. It is indigenous to regions of South and Central America. It has been introduced into India in recent years as a medicinal plant used in the management of diabetes, which is why it is popularly known as the “insulin plant”[1]. In southern India, the plant is frequently cultivated as an ornamental species and has also naturalized in several areas[2]. In traditional practice, it is used to help regulate blood glucose levels and individuals with diabetes are known to consume one leaf daily for this purpose [3]. Among the tribal communities of the Kolli Hills in the Namakkal district of Tamil Nadu. The leaves of C. igneus are recognized as an effective remedy for diabetes[4].The plant is a member of the family Costaceae. Nakai elevated Costaceae to family status based on distinctive features such as spirally arranged leaves and rhizomes lacking aromatic essential oils. Prior to this classification, ENGLER and PRANTL had placed the group as a subfamily of Costoideae within the Zingiberaceae. Its distinct taxonomic position is supported by several morphological and anatomical characteristics including a well-developed aerial shoot system with firm and often branched stems.[5] The leaves are arranged in a low spiral pattern with specific divergence angles. The family Costaceae comprises four genera and nearly 200 species. With the genus Costus being the most extensive containing around 150 species predominantly found in tropical regions.

Taxonomical Classification of Costus igneus Plant :

Table.No.1. Taxonomical classification table for Costus igneus plant

Botanical Name

Costus Igneus N.E.Br.

Domain

Eukaryota

Kingdom

Plantae

Subkingdom

Viridaeplantae

Phyllum

Tracheophyta

Subphyllum

Euphyllaphytina

Infraphyllum

Radiatopses

Class

Liliopsida

Subclass

Commelinidae

Order

Zingiberales

Superorder

Zingiberaceae

Family

Costaceae

Subfamily

Asteroidae

Tribe

Coreopsidae

Genus

Costus

Specific epithet

Igneus

PLANT PROFILE :

Figure.No.1. Costus Igneus Plant

  1. Synonym : - Insulin plant, Honi, Pushkarmula
  2. Biological Source : - It consists of fresh as well as dried leaves of plant Costus igneus belonging to the family Costaceae.
  3. Active Chemical Constituents : - It contains Carbohydrates, Proteins, Triterpenoids, Α-Tocopherol, Alkaloids, Flavonoids, Steroids, Saponins, Tannins, Ascorbic Acid, other traces amount of Potassium and Calcium.
  4. Uses : - It is mainly used as anti-diabetic, anti-inflammatory, anti-oxidant and anti-cancer agent.

Morphology : The plant is a perennial herb with an upright and spreading growth habit, typically reaching a height of about two feet. It has tall stems tend to bend and trail along the ground as they mature. The leaves are simple, alternately arranged with smooth margins and an oblong shape remaining green throughout the year. They usually measure between 4 and 8 inches in length and display prominent venation. This tropical evergreen is characterized by large, glossy, dark green leaves with paler undersides, arranged spirally around the stem to form attractive, arching clusters that emerge from underground rhizomes. During warmer seasons, the plant produces showy orange flowers measuring approximately 1.5 inches in diameter, borne on cone-shaped inflorescences at the ends of branches[6]. The fruits are small, inconspicuous, less than 0.5 inch in size and exhibit a green to multi-coloured appearance.

Major Constituents of Essential Oil :

Table.No.2.Table for Stem oil, Leaf oil and Rhizome oil.

Stem oil (%)

Leaf oil (%)

Rhizome oil (%)

Hexadecanoic acid (28.3)

Hexadecanoic acid  (24.51)

Hexadecanoic acid (25.26)

9,12-Octadecanoic acid (18.33)

2-pentalol (22.48)

9,12-Octadecanoic acid (7.74)

Dodecanoic acid (5.62)

Dodecanoic acid (3.96)

Dodecanoic acid (16.56)

Linalyl propanoate (6.03)

β-ionone (8.69)

Tetradecanoic acid (10.20)

Tetradecanoic acid (4.82)

Farnesyl acetone (7.04)

Linalool (8.48)

A-eudesmol (3.55)

A-ionone (8.01)

α-terpineol (4.44)

γ-eudesmol (3.21)

 

 

4-ethoxy phenol (3.06)

 

 

Treatment of Diabetes Mellitus :

The Diabetes Mellitus can be treated by using the various synthetic medications as follows :

  1. Metformin
  2. Dapagliflozin
  3. Sitagliptine
  4. Vildagliptine
  5. Glipizide

But due to continous administration of these medications or drugs, some adverse effects may harm the human body and health. Some common adverse effects can be occurs in human body as follows :

  1. Liver toxicity
  2. Kidney failure
  3. Hepato-renal Dysfunction
  4. Gastrointestinal issues
  5. Weight changes

Therefore, to overcome the side effects which induced due to the synthetic medications, the herbal plant named Costus igneus plays a major role in treating or managing the diabetes mellitus. The plant has less adverse effects than any other drugs or medications.

Management of Diabetes Mellitus :

Costus igneus, illustrated in Figure 1, belongs to the family Costaceae and is commonly referred to as the spiral or helical flag. The species is native to eastern regions of Brazil, particularly the states of Bahia and Espírito Santo, as well as other parts of South America[7]. It has been introduced into India more recently and is widely cultivated as an ornamental plant in Kerala[8]. The plant grows well under tropical climatic conditions. It bears simple, alternately arranged, smooth-edged, oblong leaves that remain evergreen and typically measure between 4 and 8 inches in length with parallel venation. The leaves are large, glossy, dark green and arranged in a spiral manner around the stem. The plant usually grows up to about 60 cm in height with longer stems often reclining on the ground. During the summer season, attractive orange flowers ranging from 2.5 to 12.5 cm in diameter are produced. Propagation is commonly achieved through stem cuttings. The leaves are traditionally consumed as a health supplement. The individuals must take two to three leaves daily for the management of diabetes, which has led to the plant being popularly known as the “insulin plant”[9].

Therapeutic Molecular Targets For Diabetes Mellitus :

  1. Insulin receptor : Insulin facilitates glycogen biosynthesis and glucose transport in cadaverous muscle while limiting protein catabolism. Insulin enhances lipogenesis and glucose uptake while confining lipolysis in adipose towel. It boosts lipogenesis and glycogen conflation and inhibits adipose acid oxidation and glycogen conflation in the liver, affecting metabolism laterally in addition to its direct physiological conduct. [10,11] 
  2. Dipeptidyl peptidase-IV : DPP- IV is vital for glucose homeostasis. It's needed for incretin (Glucagon- suchlike peptide- 1 (GLP- 1) and Gastric inhibitory polypeptide (GIP)) breakdown as incretins allow the body to produce further insulin when it asked and minimize the position of glucose the liver produces and its impediments act by boosting incretin situations, which elevate insulin stashing, stymie glucagon release, lower blood sugar situations, and slow stomach evacuating. [11,12]
  3. Peroxisome proliferator-activated receptor-gamma : When the agonist is bound, PPARs construct heterodimers involving retinoid X receptors and engage with cofactors to accelerate the rate of gene recap. PPARs play a crucial metabolic part as controllers of lipid metabolism and lipid detectors. Thyroid and steroid receptors are members of the PPAR superfamily of nuclear receptors. PPAR- γ is set up in a variety of apkins (e.g. fat, cadaverous muscle, and liver). Its stimulation increases the recap of genes garbling glucose and lipid metabolism, adipocyte development, and insulin signalling. [12,13] 

Figure.No.2. Therapeutic targets for diabetes mellitus and their underlying mechanisms: (a) IR, (b) DPP-IV, and (c) PPAR-γ.

Bioinformatics attributes cost-effective and expedited work involved in designing trials, executing them and enforcing laboratory trials. Physiochemical principles and intricate scientific calculation ways are combined in a new way via molecular docking. Grounded on the typical commerce between the receptor and ligand and medicine patch, docking aids in drug development. It aids the assiduity in concentrating on substances having the topmost eventuality against a specific target[14]. In this investigative work, Manasi Yadav et al. had reported that the phytoconstituents of Costus igneus and for this an activator of Insulin receptor (IR), Dipeptidyl Peptidase- IV (DPPIV) asset, and an agonist of Peroxisome proliferator actuated receptor- gamma (PPAR- γ) were chosen as remedial molecular targets for diabetes mellitus.

Phytochemical Constituents of Costus igneus Plant :

  1. Corsolic acid (C30H48O4)
  1. Diosgenin (C27H42O3)
  1. β-sitosterol (C29H50O)
  1. Quercetin (C15H10O7)
  1. Catechin (C15H14O6)
  1. Roseoside (C19H30O8)
  1. Epicatechin (C15H14O6)
  1. Kaempferol (C15H10O6)
  1. β-amyrin (C30H50O)
  1. Hexadecanoic acid (C16H32O2)
  1. Epigallocatechin gallate (C22H18O11)
  1. Stigmasterol (C29H48O)
  1. Tetradecanoic acid (C14H28O2)
  1. Oleic acid (C18H34O2)
  1. Squalene (C30H50)
  1. Lupeol (C30H50O)
  1. β-carotene (C40H56)
  1. Glycyrrhetinic acid (C30H46O4)
  1. α-tocopherol (C29H50O2)
  1. Farnesyl acetone (C18H30O)

CONCLUSION :

This review supports the therapeutic potential of the leaves in diabetes. The anti?diabetic effect of its leaves is currently been tested in diabetic patients. Studies reveal its role in various diseases, which opens up new clinical research areas. Medicinal plants provide safer and more inexpensive alternatives as follows :

  1. Conventional medicines are expensive and often have negative side effects.
  2. The anti-diabetic impact of their leaves is currently being investigated in diabetic patients.
  3. Medicinal plants are more effective than traditional treatments.
  4. Insulin plant leaves (Costus igneus) lowered fasting and postprandial blood sugar levels in rats with dexamethasone-induced hyperglycemia, returning them to normal levels.

REFERENCES

  1. Jose, B. and Reddy, L.J., 2010. Analysis of the essential oils of the stems, leaves and rhizomes of the medicinal plant Costus pictus from southern India. International journal of pharmacy and pharmaceutical sciences, 2(Suppl 2), pp.100-101.
  2. Benny, M. (2004) ‘Insulin plant in gardens’, Natural Product Radiance, 3, pp. 349–350.
  3. Devi, V.D. and Urooj, A., 2008. Hypoglycemic potential of Morus indica. L and Costus igneus. Nak.--a preliminary study. Indian journal of experimental biology, 46(8), pp.614-616.
  4. Elavarasi, S. and Saravanan, K., 2012. Ethnobotanical study of plants used to treat diabetes by tribal people of Kolli Hills, Namakkal District, Tamilnadu, Southern India. Int J Pharm Tech Res, 4(1), pp.404-411.
  5. Pazhanichamy, K., Pavithra, S., Rubini, S., Lavanya, B., Ramya, I. and Eevera, T., 2010. Morphological, anatomical and proximate analysis of leaf, root, rhizome of Costus igneus. Journal of pharmacy Research, 3(4), pp.747-752.
  6. Gilman, E.F., 2012. Costus igneus. Fact sheet. FPS 151. EDIS Electronic Data Information Source UF/IFAS, 1, pp.1-3.
  7. Hegde, P.K., Rao, H.A. and Rao, P.N., 2014. A review on Insulin plant (Costus igneus Nak). Pharmacognosy reviews, 8(15), p.67.
  8. Deogade, M.S., Wanjari, A. and Lohakare, S.C., 2014. Pharmacognostical and phytochemical study of Costus igneus NE Br leaf. Journal of Indian System of Medicine, 2(4), pp.174-178.
  9. Joshi, B.N., Munot, H., Hardikar, M. and Kulkarni, A.A., 2013. Orally active hypoglycemic protein from Costus igneus NE Br.: an in vitro and in vivo study. Biochemical and biophysical research communications, 436(2), pp.278-282.
  10. Perry, R.J., Camporez, J.P.G., Kursawe, R., Titchenell, P.M., Zhang, D., Perry, C.J., Jurczak, M.J., Abudukadier, A., Han, M.S., Zhang, X.M. and Ruan, H.B., 2015. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell, 160(4), pp.745-758.
  11. Kasina, S.V.S.K. and Baradhi, K.M., 2019. Dipeptidyl peptidase iv (DPP IV) inhibitors.
  12. Dixon, E.D., Nardo, A.D., Claudel, T., Trauner, M. and Popper, H. (2021) ‘The role of lipid sensing nuclear receptors (PPARs and LXR) and metabolic lipases in obesity, diabetes and NAFLD’, Genes, 12(5), p. 645.
  13. Hardikar, M.R., Varma, M.E., Kulkarni, A.A., Kulkarni, P.P. and Joshi, B.N., 2016. Elucidation of hypoglycemic action and toxicity studies of insulin-like protein from Costus igneus. Phytochemistry, 124, pp.99-107.
  14. Chevalier, S., Burgess, S.C., Malloy, C.R., Gougeon, R., Marliss, E.B. and Morais, J.A., 2006. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes, 55(3), pp.675-681.
  15. Shinde, S., Surwade, S. and Sharma, R., 2022. Costus ignus: insulin plant and it’s preparations as remedial approach for diabetes mellitus. International Journal of Pharmaceutical Sciences and Research, 13, pp.1551-1558.
  16. Chaudhary, R.P. and Mani, M., 2025. Comprehensive Pharmacognostical and Phytochemical investigation of Leucomeris spectabilis leaves using GC–MS analysis. Journal of Neonatal Surgery, 14(29s), p.847.
  17. Yadav, M., Yadav, P., Yadav, J.P. and Kataria, S.K., 2024. Novel derivatives of Costus igneus towards potentiality against diabetes mellitus receptors: ADME/Tox profiling, Computational Docking, and Molecular Dynamics Simulation study. Journal of Taibah University for Science, 18(1), p.2370107.
  18. Kankariya P., Darade, R.R. and Dhamane, P.S., 2024. A Review On Costus Igneus Or Insulin Plant.
  19. More, R.S. and Baviskar, P.S., Phytochemical Analysis Of Different Solvent Extracts Of Costus Igneus.
  20. Athilli, L., Siddiqui, A.F., Hussain, F. and Parvez, E.A.H., 2021. Pharmacognostic study and pharmacological potentials of Costus igneus plant–Review. International Journal of Pharmacognaosy, 8(12), pp.476-486.
  21. Khan, M.E., Odokpe, A.U. and Tor-Anyiin, T.A., 2020. Isolation And Characterization Of Stigmasterol And β-Sitosterol From Cassia Sieberiana (Fabaceae) Leaf Extract. Journal of Chemical Society of Nigeria, 45(1).
  22. Okoro, I., Tor-Anyiin, T., Igoli, J., Noundou, X. and Krause, R., 2018. Isolation and Characterisation of Stigmasterol and β–Sitosterol from Anthocleista djalonensis A. Chev. Asian Journal of Chemical Sciences, 3(4), pp.1-5.
  23. Pierre, L.L. and Moses, M.N., 2015. Isolation and characterisation of stigmasterol and β-sitosterol from Odontonema strictum (acanthaceae). Journal of Innovations in Pharmaceuticals and Biological Sciences, 2(1), pp.88-95.
  24. Hegde, P.L., Harini, A., Kumar, K.S. and Rao, P.N., 2016. Macro-microscopy and TLC atlas of leaves of Costus igneus Nak. Journal of Ayurveda Medical Sciences, 1(1).

Reference

  1. Jose, B. and Reddy, L.J., 2010. Analysis of the essential oils of the stems, leaves and rhizomes of the medicinal plant Costus pictus from southern India. International journal of pharmacy and pharmaceutical sciences, 2(Suppl 2), pp.100-101.
  2. Benny, M. (2004) ‘Insulin plant in gardens’, Natural Product Radiance, 3, pp. 349–350.
  3. Devi, V.D. and Urooj, A., 2008. Hypoglycemic potential of Morus indica. L and Costus igneus. Nak.--a preliminary study. Indian journal of experimental biology, 46(8), pp.614-616.
  4. Elavarasi, S. and Saravanan, K., 2012. Ethnobotanical study of plants used to treat diabetes by tribal people of Kolli Hills, Namakkal District, Tamilnadu, Southern India. Int J Pharm Tech Res, 4(1), pp.404-411.
  5. Pazhanichamy, K., Pavithra, S., Rubini, S., Lavanya, B., Ramya, I. and Eevera, T., 2010. Morphological, anatomical and proximate analysis of leaf, root, rhizome of Costus igneus. Journal of pharmacy Research, 3(4), pp.747-752.
  6. Gilman, E.F., 2012. Costus igneus. Fact sheet. FPS 151. EDIS Electronic Data Information Source UF/IFAS, 1, pp.1-3.
  7. Hegde, P.K., Rao, H.A. and Rao, P.N., 2014. A review on Insulin plant (Costus igneus Nak). Pharmacognosy reviews, 8(15), p.67.
  8. Deogade, M.S., Wanjari, A. and Lohakare, S.C., 2014. Pharmacognostical and phytochemical study of Costus igneus NE Br leaf. Journal of Indian System of Medicine, 2(4), pp.174-178.
  9. Joshi, B.N., Munot, H., Hardikar, M. and Kulkarni, A.A., 2013. Orally active hypoglycemic protein from Costus igneus NE Br.: an in vitro and in vivo study. Biochemical and biophysical research communications, 436(2), pp.278-282.
  10. Perry, R.J., Camporez, J.P.G., Kursawe, R., Titchenell, P.M., Zhang, D., Perry, C.J., Jurczak, M.J., Abudukadier, A., Han, M.S., Zhang, X.M. and Ruan, H.B., 2015. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell, 160(4), pp.745-758.
  11. Kasina, S.V.S.K. and Baradhi, K.M., 2019. Dipeptidyl peptidase iv (DPP IV) inhibitors.
  12. Dixon, E.D., Nardo, A.D., Claudel, T., Trauner, M. and Popper, H. (2021) ‘The role of lipid sensing nuclear receptors (PPARs and LXR) and metabolic lipases in obesity, diabetes and NAFLD’, Genes, 12(5), p. 645.
  13. Hardikar, M.R., Varma, M.E., Kulkarni, A.A., Kulkarni, P.P. and Joshi, B.N., 2016. Elucidation of hypoglycemic action and toxicity studies of insulin-like protein from Costus igneus. Phytochemistry, 124, pp.99-107.
  14. Chevalier, S., Burgess, S.C., Malloy, C.R., Gougeon, R., Marliss, E.B. and Morais, J.A., 2006. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes, 55(3), pp.675-681.
  15. Shinde, S., Surwade, S. and Sharma, R., 2022. Costus ignus: insulin plant and it’s preparations as remedial approach for diabetes mellitus. International Journal of Pharmaceutical Sciences and Research, 13, pp.1551-1558.
  16. Chaudhary, R.P. and Mani, M., 2025. Comprehensive Pharmacognostical and Phytochemical investigation of Leucomeris spectabilis leaves using GC–MS analysis. Journal of Neonatal Surgery, 14(29s), p.847.
  17. Yadav, M., Yadav, P., Yadav, J.P. and Kataria, S.K., 2024. Novel derivatives of Costus igneus towards potentiality against diabetes mellitus receptors: ADME/Tox profiling, Computational Docking, and Molecular Dynamics Simulation study. Journal of Taibah University for Science, 18(1), p.2370107.
  18. Kankariya P., Darade, R.R. and Dhamane, P.S., 2024. A Review On Costus Igneus Or Insulin Plant.
  19. More, R.S. and Baviskar, P.S., Phytochemical Analysis Of Different Solvent Extracts Of Costus Igneus.
  20. Athilli, L., Siddiqui, A.F., Hussain, F. and Parvez, E.A.H., 2021. Pharmacognostic study and pharmacological potentials of Costus igneus plant–Review. International Journal of Pharmacognaosy, 8(12), pp.476-486.
  21. Khan, M.E., Odokpe, A.U. and Tor-Anyiin, T.A., 2020. Isolation And Characterization Of Stigmasterol And β-Sitosterol From Cassia Sieberiana (Fabaceae) Leaf Extract. Journal of Chemical Society of Nigeria, 45(1).
  22. Okoro, I., Tor-Anyiin, T., Igoli, J., Noundou, X. and Krause, R., 2018. Isolation and Characterisation of Stigmasterol and β–Sitosterol from Anthocleista djalonensis A. Chev. Asian Journal of Chemical Sciences, 3(4), pp.1-5.
  23. Pierre, L.L. and Moses, M.N., 2015. Isolation and characterisation of stigmasterol and β-sitosterol from Odontonema strictum (acanthaceae). Journal of Innovations in Pharmaceuticals and Biological Sciences, 2(1), pp.88-95.
  24. Hegde, P.L., Harini, A., Kumar, K.S. and Rao, P.N., 2016. Macro-microscopy and TLC atlas of leaves of Costus igneus Nak. Journal of Ayurveda Medical Sciences, 1(1).

Photo
Parag Wankhede
Corresponding author

Institute of Pharmacy and Research, Badnera, Amravati, Maharashtra 444701

Photo
Dr. S. J. Dighade
Co-author

Institute of Pharmacy and Research, Badnera, Amravati, Maharashtra 444701

Photo
S. A. Thombre
Co-author

Institute of Pharmacy and Research, Badnera, Amravati, Maharashtra 444701

Parag Wankhede, Dr. S. J. Dighade, S. A. Thombre, A Review on Costus Igneus Plant, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 1, 149-157. https://doi.org/10.5281/zenodo.18131591

More related articles
Evaluation and Comparative Study of Formulated, Br...
Suvarna Kasi, R. Malliswari, Dr. B. Nagamani, K. Bhavana, G. Sai ...
Pharmacological Potential of Bryophyllum pinnatum:...
Pallavi Sambarkar, Vaishnavi Deshmukh, Narendra Dharkar, Wadhave ...
A Review On 'Mukul Myrrh Tree' Formulations Used i...
Parvez Shaikh, Pabitra Bhandari, Pratiksha Phad, Dnyaneshwari Jad...
Related Articles
Enhancement of Solubility of Nifedipine by Solid Dispersion Technique...
G. Jyothi, M. Sudhakar, A. Akshaya, A. Navanitha, A. Hanuma, Amtul Mateen, A. Satheesh, ...
The Evolution of Prodrug Strategies: From Simple Carriers to Smart, Targeted Sys...
Piyush Shewale , Bhavesh Satbhai , Mudassar Shah, Suvarna Katti, ...
Review on Pharmacological and Pharmacognostic Study of Moringa Plant...
Shweta Kothimbire, Bhagwan Khedkar, Puja Kate, C. V. N. Rao, ...
Formulation and Evaluation of Antimicrobial Herbal Soap by Using Turmeric, Orang...
Priyanka Devarshi, Mitali Chougule, Shubham Bhosale, Shrutika Kumbhar, ...
Evaluation and Comparative Study of Formulated, Branded & Generic Linagliptin Ta...
Suvarna Kasi, R. Malliswari, Dr. B. Nagamani, K. Bhavana, G. Sai Lakshmi, R. Lalitha, B. Nikhil Sai,...
More related articles
Evaluation and Comparative Study of Formulated, Branded & Generic Linagliptin Ta...
Suvarna Kasi, R. Malliswari, Dr. B. Nagamani, K. Bhavana, G. Sai Lakshmi, R. Lalitha, B. Nikhil Sai,...
Pharmacological Potential of Bryophyllum pinnatum: A Comprehensive Review...
Pallavi Sambarkar, Vaishnavi Deshmukh, Narendra Dharkar, Wadhave Amol, ...
A Review On 'Mukul Myrrh Tree' Formulations Used in Ayurveda "(Guggulu)"...
Parvez Shaikh, Pabitra Bhandari, Pratiksha Phad, Dnyaneshwari Jadhav, Pranit Waware, ...
Evaluation and Comparative Study of Formulated, Branded & Generic Linagliptin Ta...
Suvarna Kasi, R. Malliswari, Dr. B. Nagamani, K. Bhavana, G. Sai Lakshmi, R. Lalitha, B. Nikhil Sai,...
Pharmacological Potential of Bryophyllum pinnatum: A Comprehensive Review...
Pallavi Sambarkar, Vaishnavi Deshmukh, Narendra Dharkar, Wadhave Amol, ...
A Review On 'Mukul Myrrh Tree' Formulations Used in Ayurveda "(Guggulu)"...
Parvez Shaikh, Pabitra Bhandari, Pratiksha Phad, Dnyaneshwari Jadhav, Pranit Waware, ...